Log on / register
Feedback | Support | My details
High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina.
Beriwal S, Heron DE, Mogus R, Edwards RP, Kelley JL, Sukumvanich P
Radiat Oncol 2008, 3:7
[Full text] [PubMed] [Related articles]


No citations for this article were found in PubMed Central.


You can also check ISI Web of Science for additional citations (subscription required)
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.